Close This website uses modern features that are not supported by your browser. Click here for more information.
Please upgrade to a modern browser to view this website properly. Google Chrome Mozilla Firefox Opera Safari
your legal news hub
Sub Menu
Search

Search

Filter
Filter
Filter
A A A

Senegal may start making vaccines by 2022

Publish date: 14 June 2021
Issue Number: 926
Diary: IBA Legalbrief Africa
Category: Intellectual property

Senegal could begin producing Covid-19 vaccines next year under an agreement with Belgian biotech group Univercells aimed at boosting Africa’s drug-manufacturing ambitions. According to a report in The Herald, as wealthy countries begin to reopen after securing vaccine supplies early, African nations are still struggling to acquire shots. On a continent of 1.3bn, only about 7m have been fully vaccinated. The collaboration highlights the opportunities created by a global push to channel money and technology towards production on a continent that makes only 1% of the vaccines it requires. Univercells announced the signing of a letter of intent for collaboration with the Institut Pasteur in Senegal’s capital, Dakar, in April. The source shared details of the proposal, which were not made public. Under the agreement, the Institut Pasteur would use vaccine production technology developed by Univercells to supply Covid-19 vaccine shots to countries across West Africa. The institute would initially begin packaging and distributing vaccines produced by Univercells in Belgium early next year. Univercells CIO Kate Antrobus confirmed that it could send vaccine doses to Senegal in early next year. Timing depends on Univercells securing regulatory approval for a vaccine production site in Belgium. Antrobus said that was expected any day now.

Full report in The Herald (subscription needed)

We use cookies to give you a personalised experience that suits your online behaviour on our websites. Otherwise, you may click here to learn more, or learn how to block or disable cookies. Disabling cookies might cause you to experience difficulties on our website as some functionality relies on cookie information. You can change your mind at any time by visiting “Cookie Preferences”. Any personal data about you will be used as described in our Privacy Policy.